• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Molecular Diagnostics 2007: Technologies, Companies, Products, Applications and WW Outlook

Posted on: Thursday, 13 September 2007, 09:00 CDT

Research and Markets (http://www.researchandmarkets.com/reports/c68317) has announced the addition of Molecular Diagnostics 2007: Technologies, Companies, Products, Applications and WW Outlook to their offering.

This report reviews, analyzes and sizes the combined molecular diagnostics product and clinical lab services markets. The study uncovers interesting information about key equipment, IVD consumables, reagents, software and services that are marketed to clinical diagnostic labs located at independent companies, hospitals, HMOs, doctors cooperatives and healthcare centers of all kinds in the developed and developing worldwide regions.

This report assesses the market and maps the competitors in this market landscape with more than 85 companies identified. The financial section sizes the market and discusses the five-year revenue projection to 2011. This study segments the market by major product and service areas, by technology, by disease/ application, and by test sample material. The report also segments the market by major world regions to see the growth opportunity.

This study reviews and analyzes major company alliances, M&As during the last two years. Large data tables summarize the alliances and M&As. The alliance table presents a large amount of partnering information.

This report reviews the molecular diagnostic technology and business trends over the next three to five years. Large and small analytical tables help the reader quickly understand the trend information.

The study methodology uses primary information that was gathered from numerous sources including in-person interviews and discussions, telephone interviews, and surveys, attendance at business presentations at healthcare technical and financial conferences as well a through secondary research. This research report is designed for people that include marketers, business development, top executives, investors, VCs, consultants, R&D managers, entrepreneurs and the like. More than 51 detailed tables or figures provide key data about items such as strategic alliances, M&As, market size, segments and the like.

This report includes 30 company profiles that provide the reader a snapshot of the companies' focus or activities. The provided Internet links help readers access companies' own web sites for further review.

1. Overview of Molecular Diagnostic Tests

2. Company Activities and Strategies

3. Technologies Used in Developing Molecular Diagnostics

4. Alliances and R&D Activity in Molecular Diagnostics

5. Market Size and Forecast for Molecular Diagnostics

6. Future Directions

7. Activities of Molecular Diagnostics Companies

8. Appendix

LIST OF TABLES

LIST OF ILLUSTRATIONS

Companies Mentioned:

- Abbott Molecular

- Affymetrix, Inc.

- Agendia B.V.

- Array Platforms

- BD Diagnostics

- Beckman Coulter, Inc.

- bioMerieux SA

- BioSite, Inc.

- BML, Inc.

- Celera Group

- Cepheid

- Chiron Corporation (Novartis)

- Dako A/S

- diaDexus, Inc.

- Diagnosticos Da America S.A. (DASA)

- Digene Corporation

- DNA Methylation MDx

- Epigenomics AG

- Exact Sciences Corporation

- Genomic Health, Inc.

- Gen-Probe, Inc.

- Innogenetics NV

- Luminex Corporation

- Myriad Genetics, Inc.

- Nanogen, Inc.

- Orion Genomics LLC

- Pure Play MDx

- Quest Diagnostics, Inc.

- Roche Molecular Diagnostics

- Siemens Medical Solutions Diagnostics

- Unilabs Group

- Veridex, LLC (J&J Co.)

For more information visit http://www.researchandmarkets.com/reports/c68317

Source: Business Wire

More News in this Category